Portugal, Oct. 29 -- Portugal based BIOJAM SA has secured contract from Instituto Portugues De Oncologia Do Porto Francisco Gentil, Epe for Adcm 3281/26- Patented Blue V 25 Mg/Ml Sol Inj - Ne 1555326. The value of the contract is worth 2700 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....